A detailed history of Atlas Capital Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 14 shares of ZTS stock, worth $2,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$2,721
Previous $2.37 Million 2.49%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$148.29 - $182.55 $8,897 - $10,953
-60 Reduced 81.08%
14 $2.08 Million
Q2 2021

Jul 30, 2021

BUY
$155.9 - $187.99 $2,182 - $2,631
14 Added 23.33%
74 $13,000
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $8,640 - $10,163
60 New
60 $9,000
Q4 2019

Jan 28, 2020

SELL
$116.25 - $133.25 $30,341 - $34,778
-261 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$112.57 - $128.43 $29,380 - $33,520
261 New
261 $32,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.